Anticoagulant Solution Citrate Phosphate Dextrose (Cpd) 3.27 g (Citric Acid SOLUTION) 3.27 G

Anticoagulant Solution Citrate Phosphate Dextrose (CPD) 3.27 G is a medical-grade solution designed for blood preservation. This solution, manufactured by MACO PhARMA in France, helps maintain blood quality during storage.

Strength

3.27 G

Pack Size

70ML

Manufacturer / TM Owner

MACO PHARMA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Anticoagulant Solution Citrate Phosphate Dextrose (CPD) 3.27 G is primarily used for the preservation of blood and blood components. It prevents clotting and maintains the integrity of blood cells during storage, ensuring they remain viable for transfusion. This solution is commonly used in medical settings where blood needs to be stored for extended periods.

Side Effects

When used as directed, Anticoagulant Solution Citrate Phosphate Dextrose (CPD) 3.27 G helps to preserve the quality of blood. It works by inhibiting the clotting process and providing essential nutrients to the blood cells, which can help extend their shelf life.

Precautions & Warnings

This solution should be handled with care and stored according to the manufacturer's instructions to maintain its efficacy. It is important to use sterile techniques when handling this solution to prevent contamination. Always follow the guidelines provided by healthcare professionals.

Avoid Interactions

Anticoagulant Solution Citrate Phosphate Dextrose (CPD) 3.27 G is generally used in controlled medical environments. It is important to ensure that it is compatible with the blood components being stored. Always consult healthcare professionals for specific interactions and compatibility.

Frequently Asked Questions

This solution is used to preserve blood and blood components by preventing clotting and maintaining cell integrity during storage.

It should be stored according to the manufacturer's instructions to maintain its efficacy and prevent contamination.

This solution is designed for general use in blood preservation, but specific compatibility should be confirmed with healthcare professionals.

The main components include citric acid, phosphate, and dextrose, which work together to preserve blood quality.

When used as directed and handled properly, this solution is safe for medical use in blood preservation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.